Literature DB >> 3578924

Corticosteroid complications in respiratory disease.

F K Kwong, M A Sue, W B Klaustermeyer.   

Abstract

Complications observed in 51 patients receiving corticosteroids for greater than 1 year for asthma and other chronic pulmonary diseases were compared retrospectively with 31 control patients who had never been on corticosteroids. The prevalence of Cushingoid features (P less than .005), ocular complications (cataracts and glaucoma, P less than .025), and skeletal complications (compression fractures of vertebrae, aseptic necrosis of the femoral head, and osteopenia, P less than .005) in the study group was significantly higher than in the control group, as was the prevalence of total complications (P less than .005). Multiple regression analysis demonstrated that serious ocular and skeletal complications were directly proportional to the total lifetime dosage of corticosteroids. The high toxicity of steroid therapy should give further impetus to the formulation of ways to reduce or avoid steroid complications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578924

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  11 in total

1.  Oral-steroid sparing effect of inhaled fluticasone propionate in children with steroid-dependent asthma.

Authors:  S Sheikh; L J Goldsmith; N Eid
Journal:  Paediatr Child Health       Date:  2000-04       Impact factor: 2.253

2.  Corticosteroid treatment and prognosis in pulmonary eosinophilia.

Authors:  S Capewell; B J Chapman; F Alexander; A P Greening; G K Crompton
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

3.  Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.

Authors:  L J Walsh; C A Wong; J Oborne; S Cooper; S A Lewis; M Pringle; R Hubbard; A E Tattersfield
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

4.  Adrenal axis suppression unrelated to the dynamics of dosing with beclomethasone monopropionate.

Authors:  Siobhan A Mulrennan; Joseph S Hogg; Richard C Teoh; Alyn H Morice
Journal:  Br J Clin Pharmacol       Date:  2006-09-19       Impact factor: 4.335

Review 5.  Oral vs inhaled asthma therapy. Pros, cons and combinations.

Authors:  L M Fabbri; M Piattella; G Caramori; A Ciaccia
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Auranofin in the treatment of steroid dependent asthma: a double blind study.

Authors:  G Nierop; W P Gijzel; E H Bel; A H Zwinderman; J H Dijkman
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

7.  Effect of orally administered beclomethasone dipropionate on calcium absorption from the gut in normal subjects.

Authors:  B J Smith; P J Phillips; P R Pannall; H J Cain; W J Leckie
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

8.  Dexamethasone and infection in preterm babies: a controlled study.

Authors:  P C Ng; M A Thomson; P R Dear
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

9.  Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: A randomized trial comparing betamethasone and dexamethasone.

Authors:  Azar Danesh; Mohsen Janghorbani; Shila Khalatbari
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

10.  Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: a randomized control trial.

Authors:  Elif Yilmazel Ucar; Omer Araz; Mehmet Meral; Esin Sonkaya; Leyla Saglam; Hasan Kaynar; Ali Metin Gorguner; Metin Akgun
Journal:  Med Sci Monit       Date:  2014-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.